| Name | corymbiferin |
|---|---|
| Synonyms |
3,4-Dimethoxy-1,5,8-trihydroxy-xanthon
1,3,8-trihydroxy-4,5-dimethoxy-xanthen-9-one 1,3,8-Trihydroxy-4,5-dimethoxy-xanthen-9-on |
| Description | Corymbiferin is one of active constituents, responsible for anti-diabetic properties. Corymbiferin improves antioxidant capacity and carbohydrate metabolism in diabetic rats, along with the improvement of histopathology of livers and pancreatic β cells[1]. |
|---|---|
| Related Catalog | |
| In Vivo | The treatment with Corymbiferin (40 mg/kg; p.o.; male Wistar rats,) reduces the FBG level significantly, similar to the effect of positive metformin on the diabetic rats[1]. Corymbiferin (400 mg/kg; p.o.) also significantly reduces the blood glucose and shows a similar effect to metformin on oral glucose tolerance test (OGTT)[1]. |
| References |
| Molecular Formula | C15H12O7 |
|---|---|
| Molecular Weight | 304.25200 |
| Exact Mass | 304.05800 |
| PSA | 109.36000 |
| LogP | 2.08020 |